ETHZilla, formerly a biotechnology firm, has pivoted to focus on Ethereum, becoming the eighth-largest public Ethereum treasury globally. CEO McAndrew Rudisill announced the shift after recognizing Ethereum's potential in the global remittance market. The company, which rebranded from Life Sciences Corp in July, now holds over 102,000 Ether tokens. Rudisill emphasized Ethereum's role as a gateway for global money supply and its applications in real-world assets. ETHZilla aims to acquire as much Ether as possible to leverage layer-2 protocols for higher yields. The company sees itself as a bridge between traditional and digital finance, with a focus on long-term technology development. Since its pivot, ETHZilla's stock has gained 44% year-to-date, reflecting its strategic shift towards building a cash-flow generating layer-2 protocol business. Rudisill predicts Ether's price could reach $20,000, driven by stablecoin growth and infrastructure demand.